Be Pharmaceuticals AG FDA Recalls

2 recalls on file across drugs, 0 of them Class I and 0 still open. This firm is not matched to a listed company.

Newest first

Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.

Product	Reason	Class	Initiated
Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution anClass IIJan 10, 2024Lack of Sterility Assurance: Aseptic process simulation fail	Lack of Sterility Assurance: Aseptic process simulation failure.	Class IIDrugs	Jan 10, 2024
Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose vialsClass IISep 5, 2023Lack of Assurance of Sterility: Powder discoloration due to	Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.	Class IIDrugs	Sep 5, 2023